Expression of E-cadherin, ß-catenin and topoisomerase IIα in leiomyosarcomas

Clinical and Translational Oncology

Volumn 11, Issue 8, 2009, Pages 548-551

  Gogou, Pinelopi N ^a   Batistatou, Anna ^a   Pakos, Emilios E ^a   Apostolikas, Nikiforos ^b   Stefanou, Dimitrios ^a   Tsekeris, Pericles G ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Catenin; E cadherin; Leiomyosarcomas; Topoisomerase II

Indexed keywords

BETA CATENIN; CADHERIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II ALPHA; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BETA CATENIN; CADHERINS; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MIDDLE AGED;

EID: 74049108291     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0401-3     Document Type: Article

References (20)

1. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455
2. Halbleib JM, Nelson WJ (2006) Cadherins in development: Cell adhesion, sorting, and tissue morphogenesis. Genes Dev 20:3199-3214
3. Muller S, Su L, Tighiouart M et al (2008) Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: Predictive and prognostic correlation. Cancer 113:97-107
4. Miyanaga A, Gemma A, Ando M et al (2008) E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib. Oncol Rep 19:377-383
5. Saito T, Oda Y, Sakamoto A et al (2000) Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma. J Pathol 192:342-350
6. Ng TL, Gown AM, Barry TS et al (2005) Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18:68-74
7. Ilyas M, Tomlinson IP (1997) The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 182:128-137
8. van Es JH, Barker N, Clevers H (2003) You Wnt some, you lose some: Oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 13:28-33
9. Iino K, Sasano H, Yabuki N et al (1997) DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: A possible marker of differentiation between adenomas and carcinomas. Mod Pathol 10:901-907
10. Tanoguchi K, Sasano H, Yabuki N et al (1998) Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor. Mod Pathol 11:186-193
11. Depowski PL, Rosenthal SI, Brien TP et al (2000) Topoisomerase IIalpha expression in breast cancer: Correlation with outcome variables. Mod Pathol 13:542-547
12. Larbcharoensub N, Leopairat J, Sirachainan E et al (2008) Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy. Hum Pathol 39:837-845
13. Haber M, Smith J, Bordow SB et al (2006) Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol 24:1546-1453
14. Yoo J, Park S, Kang CS et al (2008) Expression of E-cadherin and p53 proteins in human soft tissue sarcomas. Arch Pathol Lab Med 126:33-38
15. Sato H, Hasegawa T, Abe Y et al (1999) Expression of E-cadherin in bone and soft tissue sarcomas: A possible role in epithelial differentiation. Hum Pathol 30:1344-1349
16. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C et al (2005) Nuclear beta-catenin expression distinguishes deep fi bromatosis from other benign and malignant fi broblastic and myofi broblastic lesions. Am J Surg Pathol 29:653-659
17. Carlson JW, Fletcher CD (2007) Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: Analysis of a series and review of the literature. Histopathology 51:509-514
18. Hasegawa T, Yokoyama R, Matsuno Y et al (2001) Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol 32:257-263
19. Gaumann A, Tews DS, Mentzel T et al (2003) Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin. Virchows Arch 442:529-537
20. Endo H, Hirokawa M, Ishimaru N et al (2004) Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma. Pathol Int 54:145-150